Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tribulatti MV et al. – These findings support a distinctive role for locally produced Gal–8 as an enhancer of otherwise borderline immune responses and also suggest that Gal–8 might fuel the reactivity at inflammatory foci.

Related Articles

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Arthritis Research & Therapy, 10/14/09    Relevance Score: 81%

Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis
Arthritis Research & Therapy, 10/07/09    Relevance Score: 81%

A Longer Duration of Polymyxin B-Immobilized Fiber Column Hemoperfusion Improves Pulmonary Oxygenation in Patients With Septic Shock
Shock, 10/20/09    Relevance Score: 80%

Radiation Treatments Made Safer for Cancer Patients
MedLinePlus, 10/23/09    Relevance Score: 79%

CD23 mediates anti-mycobacterial activity of human macrophages
Infection and Immunity, 10/20/09    Relevance Score: 78%

Today in Hematology/Oncology...keeping you current

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09

Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address